Form 4 for COR Cencora
Accepted 2021-10-14 00:00:00 ET · period of report 2021-10-12 · accession 0001127602-21-027080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-14 | 2021-10-12 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | S - Sale+OE | $119.79 | -24.3K | 184.6K | -12% | -$2.91M |
| DM | 2021-10-14 | 2021-10-12 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $87.53 | +24.3K | 208.8K | +13% | +$2.12M |
| DM | 2021-10-14 | 2021-10-12 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -24.3K | 51.1K | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-12 | S | D | 24,265 | $119.79 | 184,579 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. |
| 2 | Common | Common Stock | 2021-10-12 | M | A | 12,784 | $98.24 | 197,363 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. |
| 3 | Common | Common Stock | 2021-10-12 | M | A | 11,481 | $75.61 | 208,844 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-10-12 | M | D | 11,481 | $0.00 | 183,680 | D | $75.61 · — to 2023-11-09 | 11,481 Common Stock | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. (F2) Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-10-12 | M | D | 12,784 | $0.00 | 51,135 | D | $98.24 · — to 2022-11-11 | 12,784 Common Stock | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21. (F3) Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19. |